| case report | Q2782326 |
| scholarly article | Q13442814 |
| P2093 | author name string | Erik J Stratman | |
| Rahul Sehgal | |||
| Jonathan E Cutlan | |||
| P2860 | cites work | Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis | Q21202966 |
| Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study | Q24816844 | ||
| IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells | Q33990291 | ||
| Sweet's syndrome revisited: a review of disease concepts | Q35548319 | ||
| Neutrophilic skin lesions in autoimmune connective tissue diseases: nine cases and a literature review | Q36151831 | ||
| Adalimumab therapy for recalcitrant pyoderma gangrenosum | Q36675139 | ||
| Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review | Q36933111 | ||
| Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review | Q37560336 | ||
| Autoimmune diseases induced by biological agents: a double-edged sword? | Q37620986 | ||
| Miscellaneous adverse events with biologic agents (excludes infection and malignancy). | Q38238715 | ||
| Cutaneous side effects of TNF-alpha inhibitors | Q38933554 | ||
| Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis | Q39995275 | ||
| Immunology of cutaneous vasculitis associated with both etanercept and infliximab | Q40430557 | ||
| Pathological role of interleukin-6 in psoriatic arthritis | Q41589635 | ||
| Development of pyoderma gangrenosum during therapy with infliximab | Q41952036 | ||
| Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. | Q45093383 | ||
| Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial. | Q45251915 | ||
| Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients | Q46274968 | ||
| Early but not lasting improvement of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease) after infliximab therapy: relationships with variations in cytokine levels in suction blister fluids | Q46729906 | ||
| Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome. | Q54021770 | ||
| B cell activation in rheumatoid arthritis patients under infliximab treatment | Q75323122 | ||
| Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease) | Q77327737 | ||
| Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis | Q81312438 | ||
| Reactivation of cutaneous psoriasis during abatacept therapy for spondyloarthropathy | Q82240117 | ||
| Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab | Q82868283 | ||
| Paradoxical reactions to targeted biological treatments: A way to treat and trigger? | Q82965207 | ||
| Psoriasis onset with tocilizumab treatment for rheumatoid arthritis | Q83555377 | ||
| Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists | Q83929177 | ||
| Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors | Q84176406 | ||
| Onset of psoriasis following treatment with tocilizumab | Q84788772 | ||
| Tocilizumab-induced psoriasiform rash in rheumatoid arthritis | Q88106144 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 41-46 | |
| P577 | publication date | 2018-04-02 | |
| P1433 | published in | Clinical Medicine & Research | Q15757811 |
| P1476 | title | Biologic Agent-Associated Cutaneous Adverse Events: A Single Center Experience | |
| P478 | volume | 16 |
| Q90622281 | Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review | cites work | P2860 |
Search more.